» Articles » PMID: 39770293

Differential TLR-ERK1/2 Activity Promotes Viral SsRNA and DsRNA Mimic-Induced Dysregulated Immunity in Macrophages

Overview
Journal Pathogens
Date 2025 Jan 8
PMID 39770293
Authors
Affiliations
Soon will be listed here.
Abstract

RNA virus-induced excessive inflammation and impaired antiviral interferon (IFN-I) responses are associated with severe disease. This innate immune response, also referred to as "dysregulated immunity" is caused by viral single-stranded RNA (ssRNA)- and double-stranded-RNA (dsRNA)-mediated exuberant inflammation and viral protein-induced IFN antagonism. However, key host factors and the underlying mechanism driving viral RNA-mediated dysregulated immunity are poorly defined. Here, using viral ssRNA and dsRNA mimics, which activate toll-like receptor 7 (TLR7) and TLR3, respectively, we evaluated the role of viral RNAs in causing dysregulated immunity. We observed that murine bone marrow-derived macrophages (BMDMs), when stimulated with TLR3 and TLR7 agonists, induced differential inflammatory and antiviral cytokine response. TLR7 activation triggered a robust inflammatory cytokine/chemokine induction compared to TLR3 activation, whereas TLR3 stimulation induced significantly increased IFN/IFN stimulated gene (ISG) response relative to TLR7 activation. To define the mechanistic basis for dysregulated immunity, we examined cell-surface and endosomal TLR levels and downstream mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kB) activation. We identified significantly higher cell-surface and endosomal TLR7 levels compared to TLR3, which were associated with early and robust MAPK (p-ERK1/2, p-P38, and p-JNK) and NF-kB activation in TLR7-stimulated macrophages. Furthermore, blocking EKR1/2 and NF-kB activity reduced TLR3/7-induced inflammatory cytokine/chemokine levels, whereas only ERK1/2 inhibition enhanced viral RNA mimic-induced IFN/ISG responses. Collectively, our results illustrate that high cell-surface and endosomal TLR7 expression and robust ERK1/2 activation drive viral ssRNA mimic-induced excessive inflammatory and reduced IFN/ISG response and blocking ERK1/2 activity would likely mitigate viral-RNA/TLR-induced dysregulated immunity.

References
1.
Nelemans T, Kikkert M . Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections. Viruses. 2019; 11(10). PMC: 6832425. DOI: 10.3390/v11100961. View

2.
Lee J, Marshall J, Bowden D . Characterization of rubella virus replication complexes using antibodies to double-stranded RNA. Virology. 1994; 200(1):307-12. DOI: 10.1006/viro.1994.1192. View

3.
Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K . Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002; 169(12):6668-72. DOI: 10.4049/jimmunol.169.12.6668. View

4.
Franks T, Chong P, Chui P, Galvin J, Lourens R, Reid A . Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol. 2003; 34(8):743-8. PMC: 7119137. DOI: 10.1016/s0046-8177(03)00367-8. View

5.
Reimann T, Buscher D, Hipskind R, Krautwald S, Lohmann-Matthes M, Baccarini M . Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol. 1994; 153(12):5740-9. View